Billaud Marie, Hill Jennifer C, Richards Tara D, Gleason Thomas G, Phillippi Julie A
Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Front Cardiovasc Med. 2018 Sep 17;5:124. doi: 10.3389/fcvm.2018.00124. eCollection 2018.
Human ascending aortic aneurysms characteristically exhibit cystic medial degeneration of the aortic wall encompassing elastin degeneration, proteoglycan accumulation and smooth muscle cell loss. Most studies have focused on the aortic media and there is a limited understanding of the importance of the adventitial layer in the setting of human aneurysmal disease. We recently demonstrated that the adventitial ECM contains key angiogenic factors that are downregulated in aneurysmal aortic specimens. In this study, we investigated the adventitial microvascular network (vasa vasorum) of aneurysmal aortic specimens of different etiology and hypothesized that the vasa vasorum is disrupted in patients with ascending aortic aneurysm. Morphometric analyses of hematoxylin and eosin-stained human aortic cross-sections revealed evidence of vasa vasorum remodeling in aneurysmal specimens, including reduced density of vessels, increased lumen area and thickening of smooth muscle actin-positive layers. These alterations were inconsistently observed in specimens of bicuspid aortic valve (BAV)-associated aortopathy, while vasa vasorum remodeling was typically observed in aneurysms arising in patients with the morphologically normal tricuspid aortic valve (TAV). Gene expression of hypoxia-inducible factor 1α and its downstream targets, metallothionein 1A and the pro-angiogenic factor vascular endothelial growth factor, were down-regulated in the adventitia of aneurysmal specimens when compared with non-aneurysmal specimens, while the level of the anti-angiogenic factor thrombospondin-1 was elevated. Immunodetection of glucose transporter 1 (GLUT1), a marker of chronic tissue hypoxia, was minimal in non-aneurysmal medial specimens, and locally accumulated within regions of elastin degeneration, particularly in TAV-associated aneurysms. Quantification of GLUT1 revealed elevated levels in the aortic media of TAV-associated aneurysms when compared to non-aneurysmal counterparts. We detected evidence of chronic inflammation as infiltration of lymphoplasmacytic cells in aneurysmal specimens, with a higher prevalence of lymphoplasmacytic infiltrates in aneurysmal specimens from patients with TAV compared to that of patients with BAV. These data highlight differences in vasa vasorum remodeling and associated medial chronic hypoxia markers between aneurysms of different etiology. These aberrations could contribute to malnourishment of the aortic media and could conceivably participate in the pathogenesis of thoracic aortic aneurysm.
人类升主动脉瘤的特征是主动脉壁出现囊性中层退变,包括弹性蛋白退变、蛋白聚糖积聚和平滑肌细胞丢失。大多数研究都集中在主动脉中层,而对于外膜层在人类动脉瘤疾病中的重要性了解有限。我们最近证明,外膜细胞外基质包含在动脉瘤性主动脉标本中下调的关键血管生成因子。在本研究中,我们调查了不同病因的动脉瘤性主动脉标本的外膜微血管网络(滋养血管),并假设升主动脉瘤患者的滋养血管受到破坏。苏木精和伊红染色的人类主动脉横截面的形态计量分析显示,动脉瘤标本中有滋养血管重塑的证据,包括血管密度降低、管腔面积增加和平滑肌肌动蛋白阳性层增厚。在二叶主动脉瓣(BAV)相关主动脉病变的标本中,这些改变并不一致,而在形态正常的三叶主动脉瓣(TAV)患者发生的动脉瘤中,通常观察到滋养血管重塑。与非动脉瘤标本相比,动脉瘤标本外膜中缺氧诱导因子1α及其下游靶点金属硫蛋白1A和促血管生成因子血管内皮生长因子的基因表达下调,而抗血管生成因子血小板反应蛋白-1的水平升高。葡萄糖转运蛋白1(GLUT1)是慢性组织缺氧的标志物,在非动脉瘤性中层标本中的免疫检测极少,且在弹性蛋白退变区域局部积聚,特别是在TAV相关动脉瘤中。GLUT1的定量分析显示,与非动脉瘤对应物相比,TAV相关动脉瘤的主动脉中层水平升高。我们在动脉瘤标本中检测到慢性炎症的证据,即淋巴细胞和浆细胞浸润,与BAV患者相比,TAV患者的动脉瘤标本中淋巴细胞和浆细胞浸润的发生率更高。这些数据突出了不同病因的动脉瘤之间滋养血管重塑和相关中层慢性缺氧标志物的差异。这些异常可能导致主动脉中层营养不良,并可能参与胸主动脉瘤的发病机制。